Advanced Human Imaging (NASDAQ:AHI), Aditxt (NASDAQ:ADTX) – Why…

Advanced Human Imaging (NASDAQ:AHI), Aditxt (NASDAQ:ADTX) – Why…



  • Digital Media Solutions, Inc. gages Shares rose 71.9% to close at $2.20 on Friday after the company received a non-binding go-private offer from Prism Data for $2.50 a share in cash.
  • GeoVax Labs, Inc. GOVX rose 50.5% to close at $1.64.
  • Aditxt, Inc. ADTX gained 37% to close at $0.1918.
  • Trinity Place Holdings Inc. TPHS rose 33.8% to $1.10.
  • American Virtual Cloud Technologies, Inc. AVCT up 31.1% to close at $0.2197. Technology company shares traded higher as stocks rebounded from recent weakness.
  • MOGU Inc. MOGU Shares gained 29.8% to close at $2.60 after the company announced a $10 million buyback program.
  • Shuttle Pharmaceuticals Holdings, Inc. SCHPH gained 26.1% to close at $38.80.
  • Annovis Bio, Inc. ANVS up 25.5% to close at $15.30.
  • Invitae Corporation NVTA up 25% to close at $4.00.
  • InMed Pharmaceuticals Inc. INM Shares rose 24.2% to close at $11.02 after the company provided an update on its research/development and commercial activities.
  • Xilio Therapeutics, Inc. XLO gained 22.8% to close at $2.75.
  • Veru Inc. VERU rose 21.9% to $15.57. The FDA recently scheduled an October 6 Adcomm meeting for emergency use approval of sabizabulin for hospitalized COVID-19 patients at high risk of ARDS.
  • Zscaler, Inc. ZS up 21.9% to close at $188.00 after the company released better-than-expected Q4 results and better-than-expected sales guidance.
  • Faraday Future Intelligent Electric Inc. FFIE rose 21.6% to close at $1.11.
  • Terns Pharmaceuticals, Inc. SWALLOW gained 20.9% to close at $5.27. Vivo Capital Surplus Fund VIII, LP, which owns 10% of Terns Pharmaceuticals, acquired a total of 600,000 shares at an average price of $3.60.
  • ProKidney Corp. PROC rose 20.4% to $9.84.
  • Biodesix, Inc. bdsx gained 19.6% to close at $1.83. The company released positive quarterly results last month.
  • EFFECTOR Therapeutics, Inc. EFTR up 17.4% to close at $0.6449.
  • eFFECTOR Therapeutics recently submitted an application for…

Source story

More to explorer